BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Investors
/
Perceptive Advisors (via Board representation)
Perceptive Advisors (via Board representation)
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$1.0B
Focus Areas
5
Top Stage
Phase 3
Investment Focus
Ophthalmology
Neurodegeneration
Metabolic Disorders
Oncology
Neurology
Portfolio Companies
Company
Stage
Valuation
Focus
MeiraGTx
Phase 3
$910.0M
Ophthalmology, Neurodegeneration
LeonaBio
Phase 3
$103.2M
Oncology, Neurology